Skip to main content
Journal of Diabetes and Metabolic Disorders logoLink to Journal of Diabetes and Metabolic Disorders
. 2021 Jul 13;20(2):1169–1178. doi: 10.1007/s40200-021-00836-w

Body impedance analyzer and anthropometric indicators; predictors of metabolic syndrome

Hamidreza Pouragha 1, Mehdi Amiri 2, Maryam Saraei 3, Gholamreza Pouryaghoub 1, Ramin Mehrdad 1,
PMCID: PMC8275900  PMID: 34277496

Abstract

Aim

Metabolic syndrome is one of the outcomes of a sedentary lifestyle in the modern world. In this study, we want to introduce the predictors of metabolic syndrome using anthropometric indices and Bio-Electrical Impedance Analysis (BIA) test values.

Method

This cross-sectional study was performed on 2284 employees of Tehran University of Medical Sciences in different job categories. Metabolic syndrome was determined according to IDF criteria. Anthropometric dimensions, para-clinical tests, basic information were collected from the participants. Also, the body analysis of the participants was performed using a BIA method.

Result

The prevalence of metabolic syndrome in this study was 23.2% based on IDF criteria, which was 21% and 26.6% in men and women, respectively. The most important factor among the components of IDF criteria was HDL deficiency. In this study, neck circumference, fat mass, visceral fat, muscle mass percentage and waist to height ratio were observed as predictors of metabolic syndrome.

Conclusion

This study realized that there is association between fat mass, fat-free mass, visceral fat and muscle mass which all are some elements of body composition analysis and metabolic syndrome as a major health issue.

Keywords: Metabolic syndrome, Body composition, Health personnel, Sedentary behavior

Introduction

Metabolic syndrome is known as a combination of diseases that increase the risk of atherosclerotic cardiovascular disease (ASCVD) and diabetes mellitus [1]. Also, with the COVID-19 disease pandemic, there is evidence of an increased risk of disease outcomes and mortality in patients with metabolic syndrome [2]. This risk factor consists of atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose-a pro thrombotic state, and pro-inflammatory state [1]. Metabolic syndrome doubles the risk of ASCVD and confers a 5 times higher risk of developing diabetes mellitus [1]. The International Diabetes Federation (IDF) estimates that about 25 percent of the world's population has metabolic syndrome [3].

More than one-fifth of countries in Asia and the Pacific are affected by metabolic syndrome [4]. The prevalence of metabolic syndrome in South Korea is 30.5% and shows an increasing trend [5]. A 25-year report found that the prevalence of metabolic syndrome in all social groups in the United States was increasing, with more than one-third of American adults having metabolic syndrome [6]. In a meta-analysis, the prevalence of metabolic syndrome in Middle Eastern countries is estimated at 25% [7]. The prevalence of metabolic syndrome in Saudi Arabia is 31.6% according to the IDF criteria [8]. About one-third of Iranian adults have metabolic syndrome [9]. In other studies, metabolic syndrome has been reported 34.2% in Iran [10] also in a report, the prevalence of metabolic syndrome in Iran was 38% according to IDF criteria [11].

Socioeconomic background and race are influential in metabolic syndrome [3]. In previous studies, Metabolic syndrome has been associated with cancers (breast, pancreatic, colon, and liver) [3]. In a study, the most prevalent component influencing metabolic syndrome is atherogenic dyslipidemia, which is associated with a decrease in HDL and an increase in cholesterol [12]. Also, the most important and common cause of metabolic syndrome was low HDL with a prevalence of 59.7% in Iran [13].

Obesity and atherogenic dyslipidemia (HDL deficiency and high triglycerides), high blood pressure, high blood sugar are among the main criteria of metabolic syndrome that have been introduced by various scientific societies such as the International Diabetes Federation (IDF), World Health Organization (WHO), the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III). In recent years, researchers have tried to introduce other predictors of metabolic syndrome in addition to the criteria that determine metabolic syndrome. Predictors of metabolic syndrome fall into three main categories. The first category is anthropometric indicators that are introduced by measuring body dimensions and their ratios. The second category of body composition is introduced with newer technologies such as Bioelectrical Impedance Analysis (BIA) and the third category are other values such as biochemical indicators and so on. Anthropometric indices and ratios predicting metabolic syndrome can be mentioned as follows: Body Mass Index BMI [1423]; Waist Circumference WC [1518, 2126]; Neck circumference [27]; Waist to Hip Ratio WHR [17, 18, 20, 21, 24, 26]; Waist to Height Ratio WHtR [1518, 20, 21, 26, 28, 29] and Neck to Height Ratio [30]. Among the body composition variables that can be used as predictors of metabolic syndrome, the following predictors have been introduced in the previous study; body fat percentage and fat mass index [15, 20, 31]; Muscle mass [31]; Fat-free mass [15, 20]; Visceral adiposity index and Visceral fat [16, 17, 23, 28, 3234]; sarcopenic obesity [35]; Lipid accumulation product LAP [5, 28]; Body adiposity index [23, 28]; Fat to muscle ratio [36] and Muscle to visceral fat ratio [36]. Other predictors of metabolic syndrome include Nonfunctioning adrenal incidentaloma NFAI [37], High TSH and subclinical hypothyroidism [38] and Uric acid [39].

Given the above and the high prevalence of metabolic syndrome in developed and developing countries, especially Iran, the need for a comprehensive and insightful look at the factors involved in metabolic syndrome is inevitable. In the following study, we try to examine some variables and predictors of metabolic syndrome among health personnel. According to this, we simultaneously examine anthropometric indices and ratios such as BMI and WHtR, and BIA variables among health service staff to realize which one of these indices is a predictor of metabolic syndrome.

Methods

This cross-sectional study was conducted in 2018–2019 as a measure of enrollment data in the Tehran University of Medical Sciences' Cohort (TEC) Study [40]. The participants in this study were 60.7% female, 39.3% male with a mean (SD) age of 43.7 (8.6) years. Participants in the study included a variety of departments; including office workers, clinical workers, laboratory staff, services workers, and security guard staff. These types of jobs are considered as permanent or contractual. Job information, type of job, type of employment, and work experience were also obtained from the participants.

Participants

Participants in this study were 2284 staff of Tehran University of Medical Sciences in various job categories, of which 898 were men and 1386 were women. In this study, part of the data collected in the TEC cohort enrollment phase was used. The sample size is given in the main study protocol article [40]. All participants voluntarily signed the informed consent form at the study center. All examinations and data collection were performed in one working day at the designated center by trained personnel and according to the approved protocol of the study. All data collection steps were supervised by independent quality control and assurance team. Inclusion criteria in this study were employment relationship with Tehran University of Medical Sciences. All staff were allowed to enter the study voluntarily. Also, there were no exclusion criteria.

Blood samples

All participants were asked to fast for 12 h before attending the study. 10 mL of venous blood was collected using a sodium fluoride tube from each participant (between 8 and 9 am). Plasma was separated by a 15-min centrifuge at 3000 rpm. Plasma was stored at − 20 °C at the laboratory. Levels of high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides were measured, using the glycerokinase oxidase/peroxidase method. The blood glucose was determined, using the glucose oxidase/peroxidase method; and blood cholesterol was measured using the esterase oxidase/peroxidase method [41].

Blood pressure measurement

The blood pressure of the participants was measured three times and the average was reported with a precision of one mm Hg. We measured the blood pressure of participants in a sitting position after a 15-min break. There was a thirty-minute interval between the first and second round measurements and a two-hour interval between the second and third rounds. Blood pressure was measured using a standard and calibrated clinical mercury manometer [42].

Anthropometry

The weight of the participants in light clothing was measured by the SECA scales with an accuracy of 0.1 kg. Height was also measured using the SECA stadiometer to an accuracy of one millimeter. Based on height and weight data, the BMI index was calculated by dividing weight (kg) by height squared (m2). Also, all circumferences were measured with an accuracy of one millimeter by a standard tape soft meter. Waist circumferences were measured while subjects were standing and measured as the minimum abdominal circumference between the xiphoid process and the umbilicus. Hip circumferences were measured as the maximum circumferences over the buttocks. Also, the waist to hip ratio (WHR) circumference is the result of dividing the circumference of the abdomen around the buttocks and the waist to height ratio (WHtR) divides abdomen circumference by height [43].

Body analyzer

One of the common methods for studying and analyzing body shape is the body composition analysis method, which is available with different technologies. There are various methods for analyzing body composition, including the use of Caliper, anthropometry, tracer dilution, densitometry, air displacement plethysmography, dual-energy X-ray absorptiometry, bioelectrical impedance analyzer (BIA), computed tomography, magnetic resonance imaging, 3D body scanning. In the BIA method, the impedance of different tissues of the body is analyzed and the composition of the body is predicted. A very weak electrical current of 800 microamperes with a frequency of 50 kHz is sent to the body and the impedance of the tissues is measured against this current. Water has a high conductivity due to the presence of electrolytes, but adipose tissue has a low conductivity [44, 45].

In the present study, body composition analysis was performed using Tanita-720 body analyzer made in Japan. At the time of measurement, all metal parts such as watches, rings, and other jewelry were removed from the person. All measurements were performed by the same trained personnel based on the same protocol. The variables studied included: Body Fat% (Percentage of total body fat), Muscle Mass% (Percentage of total muscle tissue in the body), Visceral Fat, Bone Mass (The mass of the bones), Fat-Free Mass FFM (Bodyweight excluding fat), Total Body Water (TBW), Extra Cellular Water (ECW), Intra Cellular Water (ICW).

Physical activity

Physical activity was calculated using the short form of the IPAQ (International Physical Activity Questionnaire) and MET (metabolic equivalent of task) hours per week (MET-hours/week). The MET scores for intense, medium, and hiking activities (for at least 10 min) were multiplied by the time each participant spent on the activity, taking into account the frequency of participation in the activities mentioned over the past week. Then, to get the sum, the scores for the various activities were summarized as MET-min/week. Finally, they fall into three categories: low, medium, and high activity [46].

Smoking status

We divided participants based on the smoking status into three categories. People who have smoked for at least one day in the last 30 days as Current smokers or an adult who has smoked 100 cigarettes in his or her lifetime. People who used to smoke but do not smoke now (have not smoked a single cigarette in the last month), a Former smoker, or an adult who has smoked at least 100 cigarettes in his or her lifetime but who had quit smoking. And people who have never smoked in their lifetime, as Never smoker (an adult who has never smoked, or who has smoked less than 100 cigarettes in his or her lifetime) [47].

Met-S and its components

In the present study, Met-S was defined according to International Diabetes Federation (IDF) criteria. Diagnostic criteria for Met-S based on IDF criteria [42] are:

  • Obesity based on abdominal circumference greater than 94 cm among men and greater than 80 cm among women or BMI above 30 kg/m2.

Plus, two of the following:

  • Raised blood triglyceride (TG) is more than 150 mg/dl or specific treatment for this lipid abnormality.

  • Reduced HDL cholesterol levels less than 40 mg/dl among men and less than 50 mg/dl among women or specific treatment for this lipid abnormality.

  • Raised blood pressure, Systolic blood pressure (SBP) greater than 130 mmHg or diastolic blood pressure (DBP) greater than 85 mmHg or treatment of previously diagnosed hypertension.

  • Raised fasting plasma glucose greater than 100 mg/dl or if a person is on high blood sugar medication or previously diagnosed with type 2 diabetes.

Met-S was assessed according to the above criteria.

Statistics

To describe qualitative data, we used frequency and percentage and for quantitative data mean and standard deviation were used. We also tested all quantitative variables for normal distribution using the Kolmogorov–Smirnov test. For quantitative data with non-normal distribution, we described the variable with mean, standard deviation, median, and range.

For univariate analysis, we used the chi-square test for association between two qualitative variables. Also, for the association between qualitative and quantitative variables, independent t-test, analysis of variance, Mann–Whitney U test, Wilcoxon, and Kruskal–Wallis were used based on the type and normality of variable. We also used logistic regression analysis to realize which variables are predictors of metabolic syndrome. Data analysis was performed using the Chicago SPSS-24 software. A P-value less than 0.05 was considered as significant.

Ethical considerations

This study was done with the approval of the ethics committee of Tehran University of Medical Sciences with the ethics code IR.TUMS.VCR.REC.1395.1484, IR.TUMS.VCR.REC.1398.246. All participants participated in this study voluntarily and with informed consent, and signed the form of informed participation in the research plan approved by the ethics committee before starting the data gathering process. Participants were free to withdraw from the study at any stage. All the identity information of the participants was registered in complete confidentiality and by the study protocol in the form of a code that was provided to the researchers to analyze the information without name and mark, or any information revealing the identity of the individuals. The authors confirm that all steps and methods have been performed according to the approval of the ethics committee of Tehran University of Medical Sciences. This study was carried out according to the Helsinki Declaration Principles.

Result:

This study was performed on 2284 employees of Tehran University of Medical Sciences. 60.7% were female and 39.3% were male. The mean (SD) age of the participants was 43.7(8.6) years, the mean (SD) age of women and men was 43.1(8.3) and 44.6(9.0) respectively. Participants were divided into seven occupational groups; office workers (51.4%), healthcare workers (7.5%), services workers (7.7%), technical staff (2.7%), laboratory staff (4.2%) security (3.4%) and other (3.1%). The participant’s height mean (SD) was 165.1(9.0), which was 159.7(5.6) and 173.4(6.7) for women and men respectively. The mean (SD) of participants’ weight was 73.5(14.5) which was 67.2(11.3) for women and 83.1 (13.6) for men.

Also, the mean (SD) of the participants’ BMI was 26.9(4.3), which was 26.4(4.4) for women and 27.6 (4.1) for men. In the BMI classification, 1.1% of the participants were underweight (BMI < 18.5 kg/m2), 35.1% were in the normal range (18.5–24.9 kg/m2), 42.7% were overweight (25–29.9 kg/m2) and 21.1% were obese (BMI ≥ 30). Among all participants, 17.1% had class 1 obesity (30–34.9 kg/m2), 3% had class 2 obesity (35–39.9 kg/m2), and 1% had class 3 obesity (BMI ≥ 40).

The prevalence of metabolic syndrome according to IDF criteria in this study was 23.2%. Prevalence of metabolic syndrome in men and women was 21% and 26.6%, respectively. According to Table 1, other measured anthropometric values such as waist circumference, neck circumference, and also the ratio of waist circumference to height have been reported. Accordingly, in this study, among anthropometric variables, the only difference was in height among participants with metabolic syndrome, and for other anthropometric variables, the difference was significant, p < 0.05.

Table 1.

Description of the variables for participants with metabolic syndrome and without it by gender in both groups

Parameters All Participants Participants with metabolic syndrome Participants without metabolic syndrome
All Participants with metabolic syndrome without metabolic syndrome P-value Female
n = 292
Male
n = 239
P-value Female
n = 1094
Male n = 659 P-value
Age year 43.7(8.6) 47.7(8.2) 42.5(8.4)  < 0.001* 48.0 (7.6) 47.3 (8.9) 0.291 41.8 (8.0) 43.6 (8.9)  < 0.001*
Height cm 165.1(9.0) 165.2(9.8) 165.1(8.8) 0.861 158.4 (5.9) 173.6 (6.6)  < 0.001* 160.1 (5.5) 173.4 (6.7)  < 0.001*
Weight kg 73.5(14.5) 81.8(15.0) 70.9(13.4)  < 0.001* 74.5 (11.8) 90.9 (13.4)  < 0.001* 65.3 (10.4) 80.2 (12.6)  < 0.001*
BMI kg/m2 26.9(4.3) 29.9(4.2) 25.9(3.9)  < 0.001* 29.7 (4.5) 30.1 (3.8) 0.142 25.5 (3.9) 26.7 (3.7)  < 0.001*
Waist circumference cm 35.5(4.1) 97.8(10.3) 86.8(10.7)  < 0.001* 93.1 (9.6) 103.7 (7.9)  < 0.001* 82.6(9.5) 93.8(8.9)  < 0.001*
Neck circumference cm 89.3(11.6) 39.1(4.0) 34.9(3.8)  < 0.001* 35.7 (1.6) 42.4 (2.4)  < 0.001* 32.5(2.1) 39.2(2.1)  < 0.001*
WHtR 0.54(0.1) 0.59(0.1) 0.53(0.1)  < 0.001* 0.59 (0.1) 0.6 (0.05) 0.002* 0.52(0.1) 0.54(0.05)  < 0.001*
FBS mg/dL 87.0(19.8) 96.2(29.2) 84.2(14.8)  < 0.001* 94.9 (28.6) 97.8 (30.0) 0.059 82.1(8.7) 87.7(20.9)  < 0.001*
TG mg/dL 120.4(64.6) 161.6(83.0) 108.0(51.9)  < 0.001* 144.5 (56.7) 182.4 (103.0)  < 0.001* 94.2(37.8) 130.9(62.9)  < 0.001*
HDL mg/dL 45.9(11.1) 42.7(12.8) 46.9(10.3)  < 0.001* 44.7 (15.4) 40.2 (8.1)  < 0.001* 48.5(10.9) 44.3(8.8)  < 0.001*
DBP mmHg 75.6(8.9) 79.9(9.2) 74.3(8.3)  < 0.001* 78.4 (8.2) 81.6 (10.0)  < 0.001* 72.9(8.0) 76.8(8.3)  < 0.001*
SBP mmHg 114.4(13.8) 122.4(14.9) 111.9(12.4)  < 0.001* 119.3 (13.8) 126.3 (15.3)  < 0.001* 108.6(11.2) 117.5(12.3)  < 0.001*
Fat Mass kg 19.9(7.4) 24.2(7.4) 18.6 (6.8)  < 0.001* 25.3 (6.9) 22.8 (7.8)  < 0.001* 19.8(6.4) 16.7(7.0)  < 0.001*
Fat Mass % 27.1(7.3) 29.8(6.5) 26.3(7.3)  < 0.001* 33.9 (4.6) 24.8 (4.9)  < 0.001* 29.9(5.5) 20.3(5.8)  < 0.001*
Fat Free Mass kg 52.9(11.0) 56.9(11.5) 51.6(10.5)  < 0.001* 48.4 (5.9) 67.4 (7.4)  < 0.001* 44.9(4.9) 63.0(7.3)  < 0.001*
Visceral Fat 6.7(3.5) 9.0(3.5) 6.0(3.1)  < 0.001* 7.2 (2.4) 11.2 (3.4)  < 0.001* 4.8(2.3) 8.1(3.4)  < 0.001*
Muscle Mass kg 40.5(9.1) 45.0(6.7) 39.0(9.3)  < 0.001* 46.5 (6.6) 43.4 (6.6)  < 0.001* 39.7(9.1) 38.1(9.5)  < 0.001*
Bone mass 2.7(0.5) 2.8(0.5) 2.6(0.5)  < 0.001* 2.4 (0.3) 3.3 (0.3)  < 0.001* 2.3(0.2) 3.1(0.3)  < 0.001*
TBW 37.8(8.0) 40.6(8.5) 36.9(7.6)  < 0.001* 34.5 (4.3) 48.3 (6.0)  < 0.001* 32.1(3.5) 45.0(5.4)  < 0.001*
ICW 21.9(5.3) 23.4(5.8) 21.4(5.0)  < 0.001* 19.3 (2.5) 28.6 (4.5)  < 0.001* 18.3(2.1) 26.8(3.9)  < 0.001*
ECW 15.9(2.9) 17.2(2.9) 15.4(2.7)  < 0.001* 15.2 (2.0) 19.7 (1.9)  < 0.001* 13.8(1.7) 18.3(1.8)  < 0.001*
Fat to muscle ratio 0.51(0.2) 0.5(0.1) 0.49(0.2)  < 0.001* 0.55 (0.1) 0.53 (0.1) 0.006* 0.52(0.2) 0.46(0.2)  < 0.001*
Current Smoker n(%) 272(11.9) 62(11.7) 210(12) 0.939 14 (4.8) 48 (20.1)  < 0.001* 36(3.3) 174(26.4)  < 0.001*
Physical activity n(%) low 1533(67.1) 340 (64.0) 1193(68.0) 0.087 214 (73.3) 126 (52.7)  < 0.001* 802(73.2) 391(59.3)  < 0.001*
mod 522(22.8) 140 (26.4) 382(21.8) 65 (22.3) 75 (31.4) 216(19.7) 166(25.2)
Vig 231(10.1) 51 (9.6) 180(10.3) 13 (4.5) 38 (15.9) 78(7.1) 102(15.5)

BMI Body Mass Index, WHtR Waist-to-Height Ratio, FBS Fasting blood sugar, TG Triglyceride, HDL High-Density Lipoproteins, DBP Diastolic Blood Pressure, SBP Systolic Blood Pressure, TBW Total Body Water, ICW Intracellular water, ECW Extracellular water

*P–V < 0.05. For univariate analysis, we used the chi-square test for association between two qualitative variables. Also, for the association between qualitative and quantitative variables, independent t-test, analysis of variance, Mann–Whitney U test, Wilcoxon, and Kruskal–Wallis were used based on the type and normality of variable

FBS, TG, and HDL have also been reported as biochemical variables as criteria for metabolic syndrome. The highest prevalence of these variables in this study is related to the HDL. That is considered as the main cause of metabolic syndrome among the main components of metabolic syndrome. Accordingly, HDL levels less than 40 mg/dl in men and less than 50 mg/dl in women have a prevalence of 54.4%. The prevalence of low level HDL was 42.7% in men and 62% in women. The prevalence of hypertension among participants in this study according to IDF definition was 23.8%. The prevalence of hypertension was 18.7% in women and 31.5% in men, respectively.

The values and variables obtained from the analysis of body composition of participants include: Fat mass, body fat percentage, fat-free mass, visceral fat, muscle mass, bone mass, TBW, ICW, ECW, and the fat to muscle ratio, the difference between patients with metabolic syndrome and healthy was significant, p < 0.05.

11.7% of study participants were current smoker and the difference between smoking in participant with metabolic syndrome and participants without metabolic syndrome was not significant, p = 0.939. In addition, the physical activity of participant with metabolic syndrome and without metabolic syndrome group was not statistically significant, p > 0.05.

None of the participants in the underweight range below 18.5 kg/m2 had metabolic syndrome. The prevalence of metabolic syndrome among normal BMI participants (18.5–24.9 kg/m2) was 5.4%. The prevalence of metabolic syndrome in overweight individuals (with a BMI range of 25–29.9) was 25.9%. Also, the prevalence of metabolic syndrome in class I obese people (BMI 30–34.9 kg/m2) was 47.6%. The prevalence in people with class II obesity (BMI between 35 and 39.9 kg/m2) was 47.8% and the prevalence of metabolic syndrome in people with class III obesity and BMI ≥ 40 kg/m2 was 69.6%. These results suggest that obesity alone can significantly increase the risk of metabolic syndrome. The prevalence of metabolic syndrome in different groups in terms of BMI classification was significant, P < 0.05.

Table 1 shows all the variables by gender for participants with metabolic syndrome and without metabolic syndrome group. All participants in this study were classified into seven occupational groups. The highest prevalence of metabolic syndrome was observed in the group of security staff with a prevalence of 37.7%. Prevalence of metabolic syndrome among other groups were: office workers 23.6%, healthcare workers 21%, service personnel 27.7%, technical staff 29%, laboratory personnel 15.8%, and other personnel 15.3%. The difference between prevalence of metabolic syndrome for different occupational groups was statistically significant, p < 0.05.

To determine the predictors of metabolic syndrome other than the main components of metabolic syndrome based on IDF criteria, we used binary logistic regression. Neck circumference, fat mass, fat free mass, visceral fat and fat percentage and waist-to-height ratio were independently observed as predictors of metabolic syndrome adjusted for sex and age with R square = 0.541 (Table 2).

Table 2.

Logistic regression for Metabolic Syndrome Predictors

95% C.I. for Odds Ratio
Variable B Odds Ratio P-value Lower Upper
Sex (F/M) 1.39 4.03 0.366 0.20 82.98
Age (year) 0.08 1.09 0.063 1.0 1.19
Neck circumferences 0.05 1.05  < 0.001* 1.03 1.083
Fat Mass 0.24 1.27 0.007* 1.07 1.51
Fat Free Mass -22.19  < 0.001 0.008*  < 0.001 0.003
Visceral fat -16.0  < 0.001  < 0.001*  < 0.001 0.001
Muscle Mass Percent 23.19 1.18 × 1010 0.008* 455.2 3.05 × 1017
Waist to Height Ratio 28.92 3.61 × 1012 0.001* 162,043.5 8.05 × 1019
Constant -34.90  < 0.001  < 0.001* 0.20 82.98

R Square = 0.541

Discussion

Many studies on the factors affecting metabolic syndrome have been performed, also previous studies have attempted to introduce predictors of metabolic syndrome. Predictors of metabolic syndrome can be classified into three categories: anthropometric variables, biochemical variables, and lifestyle.

In the present study, the association of body composition variables and metabolic syndrome were studied in the employees of a large university with the objective of providing health, medical and educational services with a staff of over 20,000 people. For this purpose, 2286 university staffs were examined and their basic variables, body analysis, anthropometry, and lifestyle on metabolic syndrome were examined.

The results of this study showed that participants with metabolic syndrome are older than healthy participants. There was no significant difference of age between men and women with metabolic syndrome. According to the findings of this study, metabolic syndrome occurs in both sexes in almost the same age range. This finding has been widely observed in previous studies [4850]. Probably the difference in prevalence of metabolic syndrome between genders can be attributed to elements other than age. Differences in the prevalence of metabolic syndrome among women and men have also been observed in previous studies [5156].

There was no significant difference of height between participants with metabolic syndrome and healthy participants. Of course, in terms of gender, the difference between the height of men and women in both groups with and without metabolic syndrom was significant.

Participants with metabolic syndrome were heavier in both sexes than healthy participants. This similarity was also observed with slight differences in BMI. In the IDF criteria, BMI is one of the primary criteria for the classification of metabolic syndrome. BMI was not significantly different between the two sexes and was almost in the same range in both groups. However, in healthy participants, the difference in BMI was significant. In the healthy group, men and women were overweight, so that the average BMI of healthy participant’s women and men was 25.5 and 26.7 respectively.

One of the anthropometric variables that was not a criterion for the inclusion of metabolic syndrome is neck circumference. In this study, it was observed that neck circumference is significantly different between participants with and without metabolic syndrome. In the group of metabolic syndrome, this difference is due to gender because there is a significant difference in the healthy group. There was also a significant difference in neck circumference between metabolic syndrome women and healthy women. This difference was also observed in the comparison between metabolic syndrome and healthy men. Previous studies have reported such an association [5770].

There was a significant difference between waist to height ratio in participants with metabolic syndrome and healthy participants. This difference was also significant in comparing women with and without metabolic syndrome. This significant difference was also observed between men. These observations were mentioned in other studies [7178].

Fasting Blood Sugar is one of the criteria for metabolic syndrome, there was a significant difference between participants with and without metabolic syndrome. But there was no difference in terms of gender, i.e., it was almost equally high in both groups of men and women.

There was a significant difference between triglyceride and HDL levels in both metabolic syndrome and healthy groups, but in participants with metabolic syndrome, TG level was higher in men than women and HDL level in women was significantly higher than men. This difference was also observed in healthy participants.

Systolic and diastolic blood pressure were significantly different in both metabolic syndrome and healthy groups. Among the metabolic syndrome group, men had higher blood pressure than women. This difference between the two genders was also observed in the healthy group.

The variables of Bio-Electrical Impedance Analysis to the determination of body composition that were studied in this study included fat mass, fat-free mass, visceral fat, muscle mass, bone mass, total body water, extracellular water (ECW), intracellular water (ICW), and also the fat to muscle ratio. In all these variables, there was a significant difference between participants with metabolic syndrome and without metabolic syndrome. Also, there was an association between women and men with and without metabolic syndrome.

Smoking did not show association with metabolic syndrom, but there was a significant difference between the two sexes so that men smoked more than women. Physical activity did not show an association between participants with metabolic syndrome and healthy ones, and a difference was observed between men and women.

BIA and anthropometric variables in addition to the constituent components of metabolic syndrome which were significant in univariate analysis entered to logistic regression, age and sex were not independent predictors of metabolic syndrome. The variables of neck circumference, fat mass, fat-free mass, visceral fat, muscle percentage, and waist-to-height ratio are independent predictors of metabolic syndrome adjusted for sex and age. In one study, BMI, waist circumference, waist-to-height ratio, and VAI variables were introduced as useful variables to assess the cardio-metabolic risk factors [16].

Based on the present study, waist to height ratio and visceral fat were introduced as predictors of metabolic syndrome. In other studies, abdominal circumference and body mass index were also introduced as predictors of metabolic syndrome [14, 24]. Body mass index and abdominal circumference, which are the main criteria of metabolic syndrome, were not included in this model.

The IDF and other similar criteria such as NTP including waist circumference and body mass index are defined as metabolic syndrome. Therefore, in the present study, these variables were not included in the regression model as predictors of metabolic syndrome, and we intended to examine other variables in addition to the main components of the criterion as being associated with metabolic syndrome. Neck circumference is also known as a predictor of metabolic syndrome. Neck circumference in another study in the Chinese population showed similar results [27]. Another study found that the ratio of abdominal circumference to pelvic circumference was a better predictor of the ratio of abdominal circumference to height in men, they found that the waist to hip ratio was a better predictor of the WHtR in men [18]. In the present study, the WHtR was observed as a predictor of metabolic syndrome in both sexes.

Also in the present study, fat mass, fat-free mass, visceral fat and muscle mass were introduced as predictors of metabolic syndrome along with anthropometric variables. Based on the observations of the present study, the elements obtained from the analysis of body composition by the BIA method are considered as predictors of metabolic syndrome. One of the findings observed in this study was an association between Fat-free mass and metabolic syndrome. On the other hand, the percentage of muscle, total fat mass and visceral fat are also associated with metabolic syndrome and are considered as predictors of this syndrome. As can be seen, all the main structures of body composition analysis are associated with metabolic syndrome.

From the observations of this study, it can be concluded that body composition analysis variables can be used as an early aid in the preventive diagnosis of metabolic syndrome, considering that the results of logistic regression analysis have been adjusted for age and sex. The use of body composition analysis by BIA variables along with anthropometric measures can be a useful tool for predicting metabolic syndrome in adults.

one of the benefits of this study is the investigation on health personnel who have not enough physical activity. An Iranian proverb says that a potter drinks water from a broken jar! This means that experts use their expertise less for themselves and more to others.Now, this matter was considered to some extent in the present study and the health personnel were examined. The present study showed that metabolic syndrome can be predicted by a simple anthropometric method and body composition analyzer (Bio-Electrical Impedance Analysis). These predictors, which were introduced in this study, could be a prognosis for metabolic syndrome even before it occurs. Even in future studies, the risk of metabolic syndrome can be assessed and predicted according to the dimensions and predictors introduced in this study. For example, what percentage of visceral fat can increase the risk of metabolic syndrome? However, the methods proposed in this study, including anthropometry and body composition as available and inexpensive methods can help predict the metabolic syndrome.

Conclusion

This study realized that there is association between fat mass, fat-free mass, visceral fat and muscle mass which all are some elements of body composition analysis and metabolic syndrome as a major health issue.

Acknowledgements

This study was supported and it was carried out by the cooperation of Tehran University of Medical Sciences employee’s cohort (TEC) study.

Declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Hamidreza Pouragha, Email: pouragha_h@razi.tums.ac.ir.

Gholamreza Pouryaghoub, Email: pourya@tums.ac.ir.

Ramin Mehrdad, Email: mehrdadr@tums.ac.ir.

References:

  • 1.Bonora E, DeFronzo RA. Complications, comorbidities and related disorders.
  • 2.Bansal R, Gubbi S, Muniyappa R. Metabolic syndrome and COVID 19: endocrine-immune-vascular interactions shapes clinical course. Endocrinology. 2020;161(10):bqaa112. doi: 10.1210/endocr/bqaa112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12. doi: 10.1111/obr.12229. [DOI] [PubMed] [Google Scholar]
  • 4.Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills A, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):1–9. doi: 10.1186/s12889-017-4041-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lee SE, Han K, Kang YM, Kim S-O, Cho YK, Ko KS, et al. Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009–2013) PloS one. 2018;13(3):e0194490. doi: 10.1371/journal.pone.0194490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Moore J, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Rev Chronic Dis. 2017;14:E24. doi: 10.5888/pcd14.160287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ansarimoghaddam A, Adineh HA, Zareban I, Iranpour S, HosseinZadeh A, Kh F. Prevalence of metabolic syndrome in Middle-East countries: meta-analysis of cross-sectional studies. Diabetes Metab Syndr. 2018;12(2):195–201. doi: 10.1016/j.dsx.2017.11.004. [DOI] [PubMed] [Google Scholar]
  • 8.Al-Rubeaan K, Bawazeer N, Al Farsi Y, Youssef AM, Al-Yahya AA, AlQumaidi H, et al. Prevalence of metabolic syndrome in Saudi Arabia-a cross sectional study. BMC Endocr Disord. 2018;18(1):1–9. doi: 10.1186/s12902-018-0244-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Farmanfarma KK, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, Ansari-Moghaddam A. Prevalence of metabolic syndrome in Iran: a meta-analysis of 69 studies. Diabetes Metab Syndr. 2019;13(1):792–799. doi: 10.1016/j.dsx.2018.11.055. [DOI] [PubMed] [Google Scholar]
  • 10.Salari N, Doulatyari PK, Daneshkhah A, Vaisi-Raygani A, Jalali R, Kord Jamshidi P, et al. The prevalence of metabolic syndrome in cardiovascular patients in Iran: a systematic review and meta-analysis. Diabetol Metab Syndr. 2020;12(1):1–10. doi: 10.1186/s13098-020-00605-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dalvand S, Niksima SH, Meshkani R, Gheshlagh RG, Sadegh-Nejadi S, Kooti W, et al. Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis. Iran J Public Health. 2017;46(4):456. [PMC free article] [PubMed] [Google Scholar]
  • 12.Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA, Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev Med Rep. 2017;7:211–215. doi: 10.1016/j.pmedr.2017.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mazloomzadeh S, Khazaghi ZR, Mousavinasab N. The prevalence of metabolic syndrome in Iran: a systematic review and meta-analysis. Iran J Public Health. 2018;47(4):473. [PMC free article] [PubMed] [Google Scholar]
  • 14.Pandey U, Midha T, Rao YK, Katiyar P, Wal P, Kaur S, et al. Anthropometric indicators as predictor of pre-diabetes in Indian adolescents. Indian Heart J. 2017;69(4):474–479. doi: 10.1016/j.ihj.2017.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mooney SJ, Baecker A, Rundle AG. Comparison of anthropometric and body composition measures as predictors of components of the metabolic syndrome in a clinical setting. Obes Res Clin Pract. 2013;7(1):e55–e66. doi: 10.1016/j.orcp.2012.10.004. [DOI] [PubMed] [Google Scholar]
  • 16.Czeczelewski M, Czeczelewski J, Czeczelewska E, Galczak-Kondraciuk A. Association of body composition indexes with cardio-metabolic risk factors. Obes Med. 2020;17:100171. [Google Scholar]
  • 17.Amato M, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest. 2013;36(7):537–543. doi: 10.3275/8943. [DOI] [PubMed] [Google Scholar]
  • 18.Esmaillzadeh A, Mirmiran P, Azizi F. Waist-to-hip ratio is a better screening measure for cardiovascular risk factors than other anthropometric indicators in Tehranian adult men. Int J Obes. 2004;28(10):1325–1332. doi: 10.1038/sj.ijo.0802757. [DOI] [PubMed] [Google Scholar]
  • 19.Unno M, Furusyo N, Mukae H, Koga T, Eiraku K, Hayashi J. The utility of visceral fat level by bioelectrical impedance analysis in the screening of metabolic syndrome—the results of the Kyushu and Okinawa Population Study (KOPS) J Atheroscler Thromb. 2012;19:462–70. doi: 10.5551/jat.11528. [DOI] [PubMed] [Google Scholar]
  • 20.Xu T, Liu J, Liu J, Zhu G, Han S. Relation between metabolic syndrome and body compositions among Chinese adolescents and adults from a large-scale population survey. BMC Public Health. 2017;17(1):1–8. doi: 10.1186/s12889-017-4238-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Pasdar Y, Moradi S, Moludi J, Saiedi S, Moradinazar M, Hamzeh B, et al. Waist-to-height ratio is a better discriminator of cardiovascular disease than other anthropometric indicators in Kurdish adults. Sci Rep. 2020;10(1):1–10. doi: 10.1038/s41598-020-73224-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Deshmukh P, Gupta S, Dongre A, Bharambe M, Maliye C, Kaur S, et al. Relationship of anthropometric indicators with blood pressure levels in rural Wardha. Indian J Med Res. 2006;123(5):657. [PubMed] [Google Scholar]
  • 23.de Oliveira CM, Ulbrich AZ, Neves FS, Dias FAL, Horimoto ARVR, Krieger JE, et al. Association between anthropometric indicators of adiposity and hypertension in a Brazilian population: Baependi Heart Study. PLoS One. 2017;12(10):e0185225. doi: 10.1371/journal.pone.0185225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Perona JS, Schmidt-RioValle J, Rueda-Medina B, Correa-Rodríguez M, González-Jiménez E. Waist circumference shows the highest predictive value for metabolic syndrome, and waist-to-hip ratio for its components, in Spanish adolescents. Nutr Res. 2017;45:38–45. doi: 10.1016/j.nutres.2017.06.007. [DOI] [PubMed] [Google Scholar]
  • 25.Shen W, Punyanitya M, Chen J, Gallagher D, Albu J, Pi-Sunyer X, et al. Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity. 2006;14(4):727–736. doi: 10.1038/oby.2006.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Schneider HJ, Glaesmer H, Klotsche J, Bohler S, Lehnert H, Zeiher AM, et al. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab. 2007;92(2):589–594. doi: 10.1210/jc.2006-0254. [DOI] [PubMed] [Google Scholar]
  • 27.Cui T, Yan Bh, Liu Z, Yang H, Gyan M, Ma Yx. Neck circumference: a valuable anthropometric measurement to detect metabolic syndrome among different age groups in China. Diabetes Metab Res Rev. 2018;34(3):e2966. doi: 10.1002/dmrr.2966. [DOI] [PubMed] [Google Scholar]
  • 28.Guo S-x, Zhang X-h, Zhang J-y, He J, Yan Y-z, Ma J-l, et al. Visceral adiposity and anthropometric indicators as screening tools of metabolic syndrome among low income rural adults in Xinjiang. Sci Rep. 2016;6(1):1–8. doi: 10.1038/srep36091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Suliga E, Ciesla E, Głuszek-Osuch M, Rogula T, Głuszek S, Kozieł D. The usefulness of anthropometric indices to identify the risk of metabolic syndrome. Nutrients. 2019;11(11):2598. doi: 10.3390/nu11112598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Selvan C, Dutta D, Thukral A, Nargis T, Kumar M, Mukhopadhyay S, et al. Neck height ratio is an important predictor of metabolic syndrome among Asian Indians. Indian J Endocrinol Metab. 2016;20(6):831. doi: 10.4103/2230-8210.192927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pigłowska M, Kostka T, Drygas W, Jegier A, Leszczyńska J, Bill-Bielecka M, et al. Body composition, nutritional status, and endothelial function in physically active men without metabolic syndrome–a 25 year cohort study. Lipids Health Dis. 2016;15(1):1–8. doi: 10.1186/s12944-016-0249-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ozhan H, Alemdar R, Caglar O, Ordu S, Kaya A, Albayrak S, et al. Performance of bioelectrical impedance analysis in the diagnosis of metabolic syndrome. J Investig Med. 2012;60(3):587–591. doi: 10.2310/JIM.0b013e318244e2d9. [DOI] [PubMed] [Google Scholar]
  • 33.Cho D-H, Kim M-N, Joo HJ, Shim WJ, Lim D-S, Park S-M. Visceral obesity, but not central obesity, is associated with cardiac remodeling in subjects with suspected metabolic syndrome. Nutr Metab Cardiovasc Dis. 2019;29(4):360–366. doi: 10.1016/j.numecd.2019.01.007. [DOI] [PubMed] [Google Scholar]
  • 34.Omuse G, Maina D, Hoffman M, Mwangi J, Wambua C, Kagotho E, et al. Metabolic syndrome and its predictors in an urban population in Kenya: a cross sectional study. BMC Endocr Disord. 2017;17(1):1–11. doi: 10.1186/s12902-017-0188-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lu C-W, Yang K-C, Chang H-H, Lee L-T, Chen C-Y, Huang K-C. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301–e307. doi: 10.1016/j.orcp.2012.02.003. [DOI] [PubMed] [Google Scholar]
  • 36.Ramírez-Vélez R, Carrillo HA, Correa-Bautista JE, Schmidt-RioValle J, González-Jiménez E, Correa-Rodríguez M, et al. Fat-to-muscle ratio: a new anthropometric indicator as a screening tool for metabolic syndrome in young Colombian people. Nutrients. 2018;10(8):1027. doi: 10.3390/nu10081027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ribeiro Cavalari EM, de Paula MP, Arruda M, Carraro N, Martins A, de Souza K, et al. Nonfunctioning adrenal incidentaloma: a novel predictive factor for metabolic syndrome. Clin Endocrinol. 2018;89(5):586–595. doi: 10.1111/cen.13822. [DOI] [PubMed] [Google Scholar]
  • 38.Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, et al. Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin Endocrinol. 2012;76(6):911–918. doi: 10.1111/j.1365-2265.2011.04328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Yu TY, Jee JH, Bae JC, Jin S-M, Baek J-H, Lee M-K, et al. Serum uric acid: a strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism. 2016;65(4):432–440. doi: 10.1016/j.metabol.2015.11.003. [DOI] [PubMed] [Google Scholar]
  • 40.Nedjat S, Mehrdad R, Yunesian M, Pouragha H, Biagi V, Monazzam-Esmaeelpour MR. Prospective cohort study on the social determinants of health: Tehran University of Medical Sciences employeescohort (TEC) study protocol. BMC Public Health. 2020;20(1):1–7. doi: 10.1186/s12889-020-09798-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.McPherson RA. Henry's Clinical Diagnosis and Management by Laboratory Methods: First South Asia Edition_e-Book: Elsevier India; 2017.
  • 42.Petrie J, O’brien E, Littler W, De Swiet M. Recommendations on blood pressure measurement. Br Med J. 1986;293(6547):611. doi: 10.1136/bmj.293.6547.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Organization WH. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008; 2011.
  • 44.Kuriyan R. Body composition techniques. Indian J Med Res. 2018;148(5):648. doi: 10.4103/ijmr.IJMR_1777_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Khalil SF, Mohktar MS, Ibrahim F. The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases. Sensors. 2014;14(6):10895–10928. doi: 10.3390/s140610895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Vasheghani-Farahani A, Tahmasbi M, Asheri H, Ashraf H, Nedjat S, Kordi R. The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study. Asian J Sports Med. 2011;2(2):106. doi: 10.5812/asjsm.34781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Feng X, Qian Z, Zhang B, Guo E, Wang L, Liu P, et al. Number of cigarettes smoked per day, smoking index, and intracranial aneurysm rupture: a case–control study. Front Neurol. 2018;9:380. doi: 10.3389/fneur.2018.00380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Suastika K, Dwipayana P, Saraswati IMR, Kuswardhani T, Astika N, Putrawan IB, et al. Relationship between age and metabolic disorders in the population of Bali. J Clin Gerontol Geriatr. 2011;2(2):47–52. [Google Scholar]
  • 49.Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index; United States, 2003–2006; 2009. [PubMed]
  • 50.Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007;7(1):1–9. doi: 10.1186/1471-2458-7-220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol. 2006;95(3):147. doi: 10.1007/s00392-006-0351-5. [DOI] [PubMed] [Google Scholar]
  • 52.Rochlani Y, Pothineni NV, Mehta JL. Metabolic syndrome: does it differ between women and men? Cardiovasc Drugs Ther. 2015;29(4):329–338. doi: 10.1007/s10557-015-6593-6. [DOI] [PubMed] [Google Scholar]
  • 53.Novak M, Björck L, Welin L, Welin C, Manhem K, Rosengren A. Gender differences in the prevalence of metabolic syndrome in 50-year-old Swedish men and women with hypertension born in 1953. J Hum Hypertens. 2013;27(1):56–61. doi: 10.1038/jhh.2011.106. [DOI] [PubMed] [Google Scholar]
  • 54.Lee S, Ko Y, Kwak C, Yim E-s. Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome. BMC Geriatr. 2016;16(1):1–8. doi: 10.1186/s12877-016-0202-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Jiang B, Zheng Y, Chen Y, Chen Y, Li Q, Zhu C, et al. Age and gender-specific distribution of metabolic syndrome components in East China: role of hypertriglyceridemia in the SPECT-China study. Lipids Health Dis. 2018;17(1):1–11. doi: 10.1186/s12944-018-0747-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Dallongeville J, Cottel D, Arveiler D, Tauber J-P, Bingham A, Wagner A, et al. The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab. 2004;48(1):43–50. doi: 10.1159/000075304. [DOI] [PubMed] [Google Scholar]
  • 57.Luo Y, Ma X, Shen Y, Xu Y, Xiong Q, Zhang X, et al. Neck circumference as an effective measure for identifying cardio-metabolic syndrome: a comparison with waist circumference. Endocrine. 2017;55(3):822–830. doi: 10.1007/s12020-016-1151-y. [DOI] [PubMed] [Google Scholar]
  • 58.Ozkaya I, Yardimci B, Tunckale A. Appropriate neck circumference cut-off points for metabolic syndrome in Turkish patients with type 2 diabetes. Endocrinol Diabetes Nutr. 2017;64(10):517–523. doi: 10.1016/j.endinu.2017.07.006. [DOI] [PubMed] [Google Scholar]
  • 59.Namazi N, Larijani B, Surkan P, Azadbakht L. The association of neck circumference with risk of metabolic syndrome and its components in adults: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2018;28(7):657–674. doi: 10.1016/j.numecd.2018.03.006. [DOI] [PubMed] [Google Scholar]
  • 60.Ben-Noun L, Laor A. Relationship of neck circumference to cardiovascular risk factors. Obes Res. 2003;11(2):226–231. doi: 10.1038/oby.2003.35. [DOI] [PubMed] [Google Scholar]
  • 61.Zhou J-y, Ge H, Zhu M-f, Wang L-j, Chen L, Tan Y-z, et al. Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol. 2013;12(1):1–7. doi: 10.1186/1475-2840-12-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Yang G-r, Yuan S-y, Fu H-j, Wan G, Zhu L-x, Bu X-l, et al. Neck circumference positively related with central obesity, overweight, and metabolic syndrome in Chinese subjects with type 2 diabetes: Beijing Community Diabetes Study 4. Diabetes Care. 2010;33(11):2465–7. doi: 10.2337/dc10-0798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Onat A, Hergenç G, Yüksel H, Can G, Ayhan E, Kaya Z, et al. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr. 2009;28(1):46–51. doi: 10.1016/j.clnu.2008.10.006. [DOI] [PubMed] [Google Scholar]
  • 64.Stabe C, Vasques ACJ, Lima MMO, Tambascia MA, Pareja JC, Yamanaka A, et al. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Clin Endocrinol. 2013;78(6):874–881. doi: 10.1111/j.1365-2265.2012.04487.x. [DOI] [PubMed] [Google Scholar]
  • 65.Silva CdCd, Zambon MP, Vasques ACJ, Rodrigues AMdB, Camilo DF, Antonio MÂR, et al. Neck circumference as a new anthropometric indicator for prediction of insulin resistance and components of metabolic syndrome in adolescents: Brazilian Metabolic Syndrome Study. Rev Paul Pediatr. 2014;32(2):221–9. doi: 10.1590/0103-0582201432210713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Morais AA, Morais UAB, Soares MMS, Romano MCC, Lamounier JA. Neck circumference in adolescents and cardiometabolic risk: a sistematic review. Rev Assoc Med Bras. 2018;64(1):54–62. doi: 10.1590/1806-9282.64.01.54. [DOI] [PubMed] [Google Scholar]
  • 67.Alzeidan R, Fayed A, Hersi AS, Elmorshedy H. Performance of neck circumference to predict obesity and metabolic syndrome among adult Saudis: a cross-sectional study. BMC obesity. 2019;6(1):13. doi: 10.1186/s40608-019-0235-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Kumar NV, Ismail MH, Mahesha P, Girish M, Tripathy M. Neck circumference and cardio-metabolic syndrome. J Clin Diagn Res. 2014;8(7):MC23. doi: 10.7860/JCDR/2014/8455.4641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Ben-Noun LL, Laor A. Relationship between changes in neck circumference and cardiovascular risk factors. Exp Clin Cardiol. 2006;11(1):14. [PMC free article] [PubMed] [Google Scholar]
  • 70.Ahbab S, Ataoğlu HE, Tuna M, Karasulu L, Çetin F, Temiz LÜ, et al. Neck circumference, metabolic syndrome and obstructive sleep apnea syndrome; evaluation of possible linkage. Med Sci Monit. 2013;19:111. doi: 10.12659/MSM.883776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Shao J, Yu L, Shen X, Li D, Wang K. Waist-to-height ratio, an optimal predictor for obesity and metabolic syndrome in Chinese adults. J Nutr Health Aging. 2010;14(9):782–785. doi: 10.1007/s12603-010-0106-x. [DOI] [PubMed] [Google Scholar]
  • 72.Hsieh SD, Muto T. Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: Proposal to use the waist-to-height ratio. Prev Med. 2006;42(2):135–139. doi: 10.1016/j.ypmed.2005.08.007. [DOI] [PubMed] [Google Scholar]
  • 73.Schneider HJ, Klotsche J, Silber S, Stalla GK, Wittchen H-U. Measuring abdominal obesity: effects of height on distribution of cardiometabolic risk factors risk using waist circumference and waist-to-height ratio. Diabetes Care. 2011;34(1):e7. doi: 10.2337/dc10-1794. [DOI] [PubMed] [Google Scholar]
  • 74.Rodea-Montero ER, Evia-Viscarra ML, Apolinar-Jiménez E. Waist-to-height ratio is a better anthropometric index than waist circumference and BMI in predicting metabolic syndrome among obese Mexican adolescents. Int J Endocrinol. 2014;2014:195407. doi: 10.1155/2014/195407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Lo K, Wong M, Khalechelvam P, Tam W. Waist-to-height ratio, body mass index and waist circumference for screening paediatric cardio-metabolic risk factors: a meta-analysis. Obes Rev. 2016;17(12):1258–1275. doi: 10.1111/obr.12456. [DOI] [PubMed] [Google Scholar]
  • 76.Zhou D, Yang M, Yuan Z-P, Zhang D-D, Liang L, Wang C-L, et al. Waist-to-Height Ratio: a simple, effective and practical screening tool for childhood obesity and metabolic syndrome. Prev Med. 2014;67:35–40. doi: 10.1016/j.ypmed.2014.06.025. [DOI] [PubMed] [Google Scholar]
  • 77.Yang H, Xin Z, Feng J-P, Yang J-K. Waist-to-height ratio is better than body mass index and waist circumference as a screening criterion for metabolic syndrome in Han Chinese adults. Medicine. 2017;96(39):e8192. doi: 10.1097/MD.0000000000008192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Bohr AD, Laurson K, McQueen MB. A novel cutoff for the waist-to-height ratio predicting metabolic syndrome in young American adults. BMC Public Health. 2016;16(1):1–9. doi: 10.1186/s12889-016-2964-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Diabetes and Metabolic Disorders are provided here courtesy of Springer

RESOURCES